Blood Cancer Discovery, 2(5), p. 86-89, 2024
DOI: 10.1158/2643-3230.bcd-23-0212
Full text: Unavailable
Summary: Single-cell RNA sequencing has emerged as a powerful technique to understand the molecular features of chimeric antigen receptor (CAR) T cells that associate with clinical outcomes. Here we discuss the common themes that have emerged from across single-cell studies of CAR T-cell therapy, and summarize the challenges in interpreting this complex data type.